12 Facts About Risperidone

Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.

Risperidone is mainly used for the treatment of schizophrenia, bipolar disorder, and irritability associated with autism.

Risperidone is effective in treating psychogenic polydipsia and the acute exacerbations of schizophrenia.

Risperidone has shown promise in treating therapy-resistant obsessive-compulsive disorder, when serotonin reuptake inhibitors alone are not sufficient.

Risperidone has proven to be effective in treatment with Attention deficit hyperactivity disorder especially in cases of aggression or with another mental condition.

Related searches

Risperidone has not demonstrated a benefit in the treatment of eating disorders or personality disorders, except for limited evidence in schizotypal personality disorder.

Risperidone has been classified as a "qualitatively atypical" antipsychotic agent with a relatively low incidence of extrapyramidal side effects that has more pronounced serotonin antagonism than dopamine antagonism.

Risperidone contains the functional groups of benzisoxazole and piperidine as part of its molecular structure.

Voltage-gated sodium channels: Because it accumulates in synaptic vesicles, Risperidone inhibits voltage-gated sodium channels at clinically used concentrations.

Risperidone was approved by the United States Food and Drug Administration in 1993 for the treatment of schizophrenia.

The applicant for this medicinal product is Laboratorios Farmaceuticos Rovi, S A Risperidone was approved for medical use in the European Union in February 2022.

Risperidone is available as a tablet, an oral solution, and an ampule, which is a depot injection.